BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10718972)

  • 21. Quality of life after surgical treatment of gastric carcinoma.
    Zieren HU; Zippel K; Zieren J; Müller JM
    Eur J Surg; 1998 Feb; 164(2):119-25. PubMed ID: 9537719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery.
    Singer S; Wollbrück D; Wulke C; Dietz A; Klemm E; Oeken J; Meister EF; Gudziol H; Bindewald J; Schwarz R
    Head Neck; 2009 Jan; 31(1):64-76. PubMed ID: 18972411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.
    Cocks K; Cohen D; Wisløff F; Sezer O; Lee S; Hippe E; Gimsing P; Turesson I; Hajek R; Smith A; Graham L; Phillips A; Stead M; Velikova G; Brown J;
    Eur J Cancer; 2007 Jul; 43(11):1670-8. PubMed ID: 17574838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Quality of life assessment in pancreatic carcinoma: results of an European multicentric study].
    Bassi C; Johnson C; Fitzsimmons D; Falconi M; Butturini G; Contro C; Frigerio I; Pederzoli P
    Chir Ital; 1999; 51(5):359-66. PubMed ID: 10738609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the EORTC QLQ-C15-PAL and the FACIT-Pal for assessment of quality of life in patients with advanced cancer.
    Lien K; Zeng L; Nguyen J; Cramarossa G; Culleton S; Caissie A; Lutz S; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):541-7. PubMed ID: 21958099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer.
    Vickery CW; Blazeby JM; Conroy T; Arraras J; Sezer O; Koller M; Rosemeyer D; Johnson CD; Alderson D;
    Eur J Cancer; 2001 May; 37(8):966-71. PubMed ID: 11334720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The European Organization for Research and Treatment of Cancer core quality of life questionnaire (QLQ-C30 version 3.0 Turkish) in cancer patients receiving palliative radiotherapy.
    Hiçsönmez A; Köse K; Andrieu MN; Güney Y; Kurtman C
    Eur J Cancer Care (Engl); 2007 May; 16(3):251-7. PubMed ID: 17508945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires.
    Pezzilli R; Morselli-Labate AM; Fantini L; Campana D; Corinaldesi R
    Dig Liver Dis; 2007 Dec; 39(12):1077-86. PubMed ID: 17692582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of EORTC quality-of-life questionnaire in Indian women with operable breast cancer.
    Parmar V; Badwe RA; Hawaldar R; Rayabhattanavar S; Varghese A; Sharma R; Mittra I
    Natl Med J India; 2005; 18(4):172-7. PubMed ID: 16252544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. French version of FACT-G: validation and comparison with other cancer-specific instruments.
    Conroy T; Mercier M; Bonneterre J; Luporsi E; Lefebvre JL; Lapeyre M; Puyraveau M; Schraub S
    Eur J Cancer; 2004 Oct; 40(15):2243-52. PubMed ID: 15454249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms.
    Hammerlid E; Taft C
    Br J Cancer; 2001 Jan; 84(2):149-56. PubMed ID: 11161369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire cervical cancer module.
    Shin DW; Ahn E; Kim YM; Kang S; Kim BG; Seong SJ; Cha SD; Park CY; Yun YH
    Oncology; 2009; 76(3):190-8. PubMed ID: 19209009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The EORTC QLQ-CX24 cervical cancer-specific quality of life questionnaire: psychometric properties in a South Asian sample of cervical cancer patients.
    Jayasekara H; Rajapaksa LC; Greimel ER
    Psychooncology; 2008 Oct; 17(10):1053-7. PubMed ID: 18203241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Utility of the questionnaire for quality of life EORTC-QLQ-C30 in psycho-oncological outcome research].
    Determann MM; Kollenbaum VE; Henne-Bruns D
    Zentralbl Chir; 2004 Jan; 129(1):14-7. PubMed ID: 15011106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy.
    Park SH; Lee WK; Chung M; Bang SM; Cho EK; Lee JH; Shin DB
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):289-94. PubMed ID: 16010588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking Populations.
    Awad MA; Denic S; El Taji H
    Ann N Y Acad Sci; 2008 Sep; 1138():146-54. PubMed ID: 18837895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in perception of quality of life issues between health professionals and patients with pancreatic cancer.
    Fitzsimmons D; George S; Payne S; Johnson CD
    Psychooncology; 1999; 8(2):135-43. PubMed ID: 10335557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study.
    Bottomley A; Gaafar R; Manegold C; Burgers S; Coens C; Legrand C; Vincent M; Giaccone G; Van Meerbeeck J; ;
    J Clin Oncol; 2006 Mar; 24(9):1435-42. PubMed ID: 16446322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer.
    Kavadas V; Blazeby JM; Conroy T; Sezer O; Holzner B; Koller M; Buckels J;
    Eur J Cancer; 2003 Jun; 39(9):1259-63. PubMed ID: 12763214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.